Hoxie J A, Haggarty B S, Bonser S E, Rackowski J L, Shan H, Kanki P J
Hematology-Oncology Section, Hospital of the University of Pennsylvania, Philadelphia 19104.
J Virol. 1988 Aug;62(8):2557-68. doi: 10.1128/JVI.62.8.2557-2568.1988.
We have analyzed a number of biological features of HTLV-IV, a retrovirus indistinguishable from a macaque isolate of simian immunodeficiency virus (SIV), and compared this virus with several strains of human immunodeficiency virus type 1 (HIV-1). Although HTLV-IV was found to be similar to HIV-1 in its tropism for CD4+ lymphocytes, its effects on CD4 expression and the ability of its externalized envelope molecule to form a complex directly with the CD4 molecule, a number of striking differences were noted. Unlike with HIV-1, the range of cells susceptible to HTLV-IV infection and syncytia formation was restricted to a subset of CD4+ cell lines, particularly those that coexpressed CD4 with human leukocyte antigen (HLA) class II antigens. An analysis of the patterns of HTLV-IV infection with B x T somatic cell hybrids indicated that for this virus, molecules in addition to CD4 were probably required to facilitate infection and cell fusion. Additional studies of HTLV-IV infection of Sup-T1 cells, which are exquisitely sensitive to cytopathic effects induced by HIV-1, demonstrated that HTLV-IV infection could occur in the absence of cytopathic effects and, remarkably, with minimal or no downmodulation of the CD4 molecule from the cell surface. The failure of HTLV-IV infection to reduce the expression of several CD4 epitopes suggested that the HTLV-IV envelope produced by Sup-T1 cells was altered in its ability to interact with or bind to CD4. Additional differences were also noted in the size of the transmembrane envelope molecule of HTLV-IV produced by Sup-T1 cells, indicating that cell-specific alterations in processing of the HTLV-IV envelope occurred during the production of virus in this cell line. Understanding the basis for these biological differences between HTLV-IV and the HIV-1 viruses may help to elucidate more general mechanisms for pathogenesis of other members of the SIV and HIV families of retroviruses.
我们分析了HTLV-IV的一些生物学特性,HTLV-IV是一种逆转录病毒,与猿猴免疫缺陷病毒(SIV)的猕猴分离株无法区分,并将这种病毒与几种1型人类免疫缺陷病毒(HIV-1)毒株进行了比较。尽管发现HTLV-IV在对CD4+淋巴细胞的嗜性、对CD4表达的影响以及其外化包膜分子直接与CD4分子形成复合物的能力方面与HIV-1相似,但仍注意到一些显著差异。与HIV-1不同,易受HTLV-IV感染和形成多核巨细胞的细胞范围仅限于CD4+细胞系的一个子集,特别是那些与人类白细胞抗原(HLA)II类抗原共表达CD4的细胞系。对B x T体细胞杂种的HTLV-IV感染模式分析表明,对于这种病毒,除了CD4之外,可能还需要其他分子来促进感染和细胞融合。对Sup-T1细胞进行的HTLV-IV感染的进一步研究表明,Sup-T1细胞对HIV-1诱导的细胞病变效应极为敏感,HTLV-IV感染可以在没有细胞病变效应的情况下发生,而且值得注意的是,细胞表面的CD4分子下调极少或没有下调。HTLV-IV感染未能降低几种CD4表位的表达,这表明Sup-T1细胞产生的HTLV-IV包膜在与CD4相互作用或结合的能力方面发生了改变。在Sup-T1细胞产生的HTLV-IV跨膜包膜分子大小方面也注意到其他差异,这表明在该细胞系产生病毒的过程中,HTLV-IV包膜的加工发生了细胞特异性改变。了解HTLV-IV和HIV-1病毒之间这些生物学差异的基础,可能有助于阐明逆转录病毒SIV和HIV家族其他成员发病机制的更一般机制。